Compensatory signalling induced in the yolk sac vasculature by deletion of TGFβ receptors in mice

作者: R. L. C. Carvalho , F. Itoh , M.-J. Goumans , F. Lebrin , M. Kato

DOI: 10.1242/JCS.013169

关键词:

摘要: Vascular development depends on transforming growth factor β (TGFβ), but whether signalling of this protein is required for the endothelial cells (ECs), vascular smooth muscle (VSMCs) or both unclear. To address this, we selectively deleted type I (ALK5, TGFBR1) and II (TβRII, TGFBR2) receptors in mice. Absence either receptor ECs resulted defects yolk sac, as seen mice lacking all cells, causing embryonic lethality at day (E)10.5. Deletion TβRII specifically VSMCs also sac; however, these were observed later stages development, allowing embryo to survive E12.5. Because TGFβ can signal via ALK1 (ACVRL1), replaced ALK5 by a mutant defective SMAD2 SMAD3 (SMAD2/3) activation that retained ability transactivate ALK1. This again caused sac vasculature with E10.5, demonstrating TGFβ/ALK1 cannot compensate lack TGFβ/ALK5-induced SMAD2/3 vivo. Unexpectedly, phosphorylation α-smooth actin (SMAα, ACTA2) expression occurred sacs ALK5–/– embryos stem undergoing vasculogenesis, processes could be blocked an ALK4 (ACVR1B)/ALK5 inhibitor. Together, data show vasculogenesis; absence ALK5, mediates consequently SMAα expression.

参考文章(55)
S. P. Oh, T. Seki, K. A. Goss, T. Imamura, Y. Yi, P. K. Donahoe, L. Li, K. Miyazono, P. ten Dijke, S. Kim, E. Li, Activin receptor-like kinase 1 modulates transforming growth factor-β1 signaling in the regulation of angiogenesis Proceedings of the National Academy of Sciences of the United States of America. ,vol. 97, pp. 2626- 2631 ,(2000) , 10.1073/PNAS.97.6.2626
A. B. Roberts, M. B. Sporn, R. K. Assoian, J. M. Smith, N. S. Roche, L. M. Wakefield, U. I. Heine, L. A. Liotta, V. Falanga, J. H. Kehrl, Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 83, pp. 4167- 4171 ,(1986) , 10.1073/PNAS.83.12.4167
A. J. M. Van Den Eijnden-Van Raaij, C. L. Mummery, Type beta transforming growth factors and activins in differentiating embryonal carcinoma cells, embryonic stem cells and early embryonic development. The International Journal of Developmental Biology. ,vol. 37, pp. 169- 182 ,(1993) , 10.1387/IJDB.8389576
Prionas Sd, Fajardo Lf, Kowalski J, Allison Ac, Kwan Hh, Transforming growth factor beta1 induces angiogenesis in vivo with a threshold pattern. Laboratory Investigation. ,vol. 74, pp. 600- 608 ,(1996)
Christine Mummery, Marie-José Goumans, Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. The International Journal of Developmental Biology. ,vol. 44, pp. 253- 265 ,(2000) , 10.1387/IJDB.10853822
A Gougos, M Letarte, Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. Journal of Biological Chemistry. ,vol. 265, pp. 8361- 8364 ,(1990) , 10.1016/S0021-9258(19)38892-1
Douglas Hanahan, Signaling Vascular Morphogenesis and Maintenance Science. ,vol. 277, pp. 48- 50 ,(1997) , 10.1126/SCIENCE.277.5322.48
Werner Risau, Mechanisms of angiogenesis Nature. ,vol. 386, pp. 671- 674 ,(1997) , 10.1038/386671A0
J Saras, H Ichijo, K Miyazono, P ten Dijke, H Toyoshima, P Schulz, C H Heldin, P Franzén, Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene. ,vol. 8, pp. 2879- 2887 ,(1993)